Cochrane Drugs and Alcohol Group: the development of systematic reviews of treatment outcome.

Mattick RP, Ali R, Auriacombe M, Davoli M, Faggiano F, Farrell M, Ferri M, Ling W.

Alcohol Alcohol. 2001 Mar-Apr;36(2):109-11. doi: 10.1093/alcalc/36.2.109.

- The aim of the Cochrane Collaboration is to promote review processes which address all aspects of health care and which can be viewed by clinicians to guide their day-to-day clinical practice. Recently, a Cochrane review group on drugs and alcohol has been developed. The Cochrane Review Group Editorial base is in Rome, Italy. There is an international editorial board with editors in the UK, Italy, France, Australia and the USA. So far, the group has published five reviews addressing treatment for opioid, cocaine and alcohol dependence. Additional reviews and protocols are in progress. A growing number of titles are registered with the group. Interested readers and potential reviewers and/or referees can contact the Cochrane Drugs and Alcohol Group Coordinator in Rome at the e-mail address:

PMID: 11259206

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.